These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 18560335)

  • 41. Transition Metal-Based Prodrugs for Anticancer Drug Delivery.
    Phillips AMF; Pombeiro AJL
    Curr Med Chem; 2019; 26(41):7476-7519. PubMed ID: 30501593
    [TBL] [Abstract][Full Text] [Related]  

  • 42. smProdrugs: A repository of small molecule prodrugs.
    Choudhury C; Kumar V; Kumar R
    Eur J Med Chem; 2023 Mar; 249():115153. PubMed ID: 36724634
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-Acting Diclofenac Ester Prodrugs for Joint Injection: Kinetics, Mechanism of Degradation, and In Vitro Release From Prodrug Suspension.
    Mertz N; Larsen SW; Kristensen J; Østergaard J; Larsen C
    J Pharm Sci; 2016 Oct; 105(10):3079-3087. PubMed ID: 27475785
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Application of Prodrug-based Drug Delivery Strategy in Anticancer Drugs.
    Liu N; Chen Q; Zhang Q; Wang J; Si R; Zhang J; Pan X
    Curr Top Med Chem; 2021; 21(24):2184-2204. PubMed ID: 34503405
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ATTEMPTS: a heparin/protamine-based triggered release system for the delivery of enzyme drugs without associated side-effects.
    Park YJ; Liang JF; Song H; Li YT; Naik S; Yang VC
    Adv Drug Deliv Rev; 2003 Feb; 55(2):251-65. PubMed ID: 12564979
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Colonic drug delivery: prodrug approach.
    Sinha VR; Kumria R
    Pharm Res; 2001 May; 18(5):557-64. PubMed ID: 11465408
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prodrugs of Antiinfective Agents: A Review.
    Piplani M; Rana AC; Sharma PC
    J Pharm Pharm Sci; 2016 Feb; 19(1):82-113. PubMed ID: 27096695
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Advances in the use of prodrugs for drug delivery to the eye.
    Taskar P; Tatke A; Majumdar S
    Expert Opin Drug Deliv; 2017 Jan; 14(1):49-63. PubMed ID: 27441817
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Liver-targeted drug delivery using HepDirect prodrugs.
    Erion MD; van Poelje PD; Mackenna DA; Colby TJ; Montag AC; Fujitaki JM; Linemeyer DL; Bullough DA
    J Pharmacol Exp Ther; 2005 Feb; 312(2):554-60. PubMed ID: 15340017
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Platinum(iv) anticancer prodrugs - hypotheses and facts.
    Gibson D
    Dalton Trans; 2016 Aug; 45(33):12983-91. PubMed ID: 27214873
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prodrugs for Improved Drug Delivery: Lessons Learned from Recently Developed and Marketed Products.
    Markovic M; Ben-Shabat S; Dahan A
    Pharmaceutics; 2020 Oct; 12(11):. PubMed ID: 33137942
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prodrugs as drug delivery system in oncology.
    Delahousse J; Skarbek C; Paci A
    Cancer Chemother Pharmacol; 2019 Nov; 84(5):937-958. PubMed ID: 31392391
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An update on prodrugs from natural products.
    Kumar SV; Saravanan D; Kumar B; Jayakumar A
    Asian Pac J Trop Med; 2014 Sep; 7S1():S54-9. PubMed ID: 25312180
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Prodrug Approach: A Successful Tool for Improving Drug Solubility.
    Jornada DH; dos Santos Fernandes GF; Chiba DE; de Melo TR; dos Santos JL; Chung MC
    Molecules; 2015 Dec; 21(1):42. PubMed ID: 26729077
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prodrug strategies to overcome poor water solubility.
    Stella VJ; Nti-Addae KW
    Adv Drug Deliv Rev; 2007 Jul; 59(7):677-94. PubMed ID: 17628203
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A novel prodrug approach for tertiary amines. 2. Physicochemical and in vitro enzymatic evaluation of selected N-phosphonooxymethyl prodrugs.
    Krise JP; Narisawa S; Stella VJ
    J Pharm Sci; 1999 Sep; 88(9):922-7. PubMed ID: 10479355
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prodrug-based nanoparticulate drug delivery strategies for cancer therapy.
    Luo C; Sun J; Sun B; He Z
    Trends Pharmacol Sci; 2014 Nov; 35(11):556-66. PubMed ID: 25441774
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A safe, simple and efficient doxorubicin prodrug hybrid micelle for overcoming tumor multidrug resistance and targeting delivery.
    Bao Y; Yin M; Hu X; Zhuang X; Sun Y; Guo Y; Tan S; Zhang Z
    J Control Release; 2016 Aug; 235():182-194. PubMed ID: 27264552
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recent updates in utilizing prodrugs in drug delivery (2013-2015).
    Amly W; Karaman R
    Expert Opin Drug Deliv; 2016; 13(4):571-91. PubMed ID: 26785610
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Current prodrug strategies via membrane transporters/receptors.
    Anand BS; Dey S; Mitra AK
    Expert Opin Biol Ther; 2002 Aug; 2(6):607-20. PubMed ID: 12171505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.